Ray Dalio Enovis Corp Transaction History

Bridgewater Associates, LP

$21.1 Billion
Q4 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Enovis Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 5,915 shares of ENOV stock, worth $206,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,915

Previous 17,588 66.37%

Holding current value

$206,492

Previous $757,000 65.79%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$38.5 - $49.33 $449,410 - $575,829	-11,673 Reduced 66.37%	5,915 $259,000
Q3 2024 Nov 13, 2024	BUY	$40.57 - $48.1 $317,379 - $376,286	7,823 Added 80.11%	17,588 $757,000
Q2 2024 Aug 14, 2024	SELL	$44.56 - $62.43 $8,555 - $11,986	-192 Reduced 1.93%	9,765 $441,000
Q1 2024 May 14, 2024	SELL	$55.44 - $63.8 $107,276 - $123,453	-1,935 Reduced 16.27%	9,957 $621,000
Q4 2023 Feb 14, 2024	SELL	$43.67 - $57.07 $138,521 - $181,026	-3,172 Reduced 21.06%	11,892 $666,000
Q3 2023 Nov 13, 2023	SELL	$51.65 - $65.54 $2.11 Million - $2.68 Million	-40,932 Reduced 73.1%	15,064 $794,000
Q2 2023 Aug 11, 2023	SELL	$52.7 - $64.12 $162,474 - $197,681	-3,083 Reduced 5.22%	55,996 $3.59 Million
Q1 2023 May 12, 2023	BUY	$49.5 - $65.92 $2.11 Million - $2.81 Million	42,637 Added 259.32%	59,079 $3.16 Million
Q4 2022 Feb 13, 2023	SELL	$44.83 - $57.43 $2.11 Million - $2.7 Million	-47,041 Reduced 74.1%	16,442 $879,000
Q3 2022 Nov 10, 2022	SELL	$46.07 - $60.1 $223,577 - $291,665	-4,853 Reduced 7.1%	63,483 $2.93 Million
Q2 2022 Aug 11, 2022	BUY	$55.0 - $70.47 $3.76 Million - $4.82 Million	68,336 New	68,336 $3.76 Million

Others Institutions Holding ENOV

# of Institutions

314

Shares Held

61.1M

Call Options Held

1.83M

Put Options Held

661K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $1.89B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account